Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targetsMasahito Kawabori(Hokkaido University)World Journal of CardiologyJanuary 1, 201310.4330/wjc.v5.i4.75Cited by 27SaveCiteExport RISWatch citationsRelated PapersTriggering Receptor Expressed on Myeloid Cells 2 (TREM2) Deficiency Attenuates Phagocytic Activities of Microglia and Exacerbates Ischemic Damage in Experimental Stroke|Journal of Neuroscience|2015|375